ConductScience.org, home

Paper7202472

Superiority of stable isotope techniques in the assessment of the bioavailability of drugs undergoing extensive first pass elimination. Studies of the relative bioavailability of verapamil tablets.

Eichelbaum M and 3 others. Eur J Clin Pharmacol, 1981. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. Superiority of stable isotope techniques in the assessment of the bioavailability of drugs undergoing extensive first pass elimination. Studies of the relative bioavailability of verapamil tablets. Papers, record 7202472. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7202472

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Superiority of stable isotope techniques in the assessment of the bioavailability of drugs undergoing extensive first pass elimination. Studies of the relative bioavailability of verapamil tablets.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
4.56
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Eichelbaum MM
2Dengler HJH J
3Somogyi AA
4von Unruh GEG E

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biological AvailabilityMajor topic
VerapamilMajor topic
Adult
Deuterium
Female
Humans
Kinetics
Male
Tablets

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11183141Absolute bioavailability in man of N-acetylprocainamide determined by a novel stable isotope method.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1183141PubMed
2314881Intraindividual variation in drug disposition.Clin Pharmacol Ther1979https://conductscience.org/library/papers/314881PubMed
3576822Determination of verapamil in human plasma by mass fragmentography using stable isotope-labelled verapamil as internal standard.Arzneimittelforschung1977https://conductscience.org/library/papers/576822PubMed
4574066Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.Circulation1979https://conductscience.org/library/papers/574066PubMed
5346345Verapamil: a review of its pharmacological properties and therapeutic use.Drugs1978https://conductscience.org/library/papers/346345PubMed
6971476Physiological disposition of verapamil in man.Cardiovasc Res1976https://conductscience.org/library/papers/971476PubMed
7805050Assessment of verapamil in the treatment of angina pectoris.Eur J Cardiol1975https://conductscience.org/library/papers/805050PubMed
81091129Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil.Am Heart J1975https://conductscience.org/library/papers/1091129PubMed
97202473Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7202473PubMed
104196671[Physiology and pharmacology of sodium, potassium, and calcium movements across the membrane].Arzneimittelforschung1972https://conductscience.org/library/papers/4196671PubMed
115814829[A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium].Pflugers Arch1969https://conductscience.org/library/papers/5814829PubMed
128298[Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)].Dtsch Med Wochenschr1976https://conductscience.org/library/papers/8298PubMed
134098332[Treatment of tachycardiac arrhythmias and arterial hypertension with verapamil].Arzneimittelforschung1970https://conductscience.org/library/papers/4098332PubMed
141096786Pharmacokinetics of drug disposition: hemodynamic considerations.Annu Rev Pharmacol1975https://conductscience.org/library/papers/1096786PubMed
1538084The metabolism of DL-[14C]verapamil in man.Drug Metab Dispos1979https://conductscience.org/library/papers/38084PubMed
16480146Bioavailability of imipramine tablets relative to a stable isotope-labeled internal standard: increasing the power of bioavailability tests.J Pharmacokinet Biopharm1979https://conductscience.org/library/papers/480146PubMed

Download CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
21801197Applications of stable isotopes in clinical pharmacology.Br J Clin Pharmacol2011https://conductscience.org/library/papers/21801197PubMed
9517368Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme induction.Br J Clin Pharmacol1998https://conductscience.org/library/papers/9517368PubMed
7621848Estimation of the absolute bioavailability of flecainide using stable isotope technique.Eur J Clin Pharmacol1995https://conductscience.org/library/papers/7621848PubMed
7206587Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single I.V. and oral administration and during chronic treatment.Klin Wochenschr1980https://conductscience.org/library/papers/7206587PubMed
7202473Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7202473PubMed
7094978Prediction of bioavailability for drugs with a high first-pass effect using oral clearance data.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7094978PubMed
6819104Application of stable labelled drugs in clinical pharmacokinetic investigations.Clin Pharmacokinet1982https://conductscience.org/library/papers/6819104PubMed
6721991Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6721991PubMed
6714292Inter- and intra-subject variation in the first-pass elimination of highly cleared drugs during chronic dosing. Studies with deuterated verapamil.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6714292PubMed
6508982Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6508982PubMed
3830249Verapamil and norverapamil in plasma and breast milk during breast feeding.Eur J Clin Pharmacol1987https://conductscience.org/library/papers/3830249PubMed
3803414Pharmacokinetics of verapamil in patients with hypertension.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3803414PubMed
3542336Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.Clin Pharmacokinet1986https://conductscience.org/library/papers/3542336PubMed
3435690Application of stable isotope methodology to study the pharmacokinetics, bioavailability and metabolism of nitrendipine after i.v. and p.o. administration.Br J Clin Pharmacol1987https://conductscience.org/library/papers/3435690PubMed
2191819Stable isotopes in clinical pharmacokinetic investigations. Advantages and disadvantages.Clin Pharmacokinet1990https://conductscience.org/library/papers/2191819PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7202472

GET https://conductscience.org/api/papers/v1/7202472/authors